Biology subjects

Panella, S.

Publications and source records attributed to Panella, S..

3 recordsLinked to original sources

bioRxiv2026

Hic sunt dracones: ancient DNA from the extinct palaeofauna of the tiny Mediterranean archipelago of Columbretes and its implications for human visitation

The Columbretes archipelago in the Mediterranean is an example of deep isolation and sporadic human interaction during the Holocene. We recovered ancient DNA from 2,600-year-old microfauna and historical museum specimens to investigate the island's extinct fauna. Despite challenging preservation conditions, we successfully recovered mitogenomes from historical Vipera latastei specimens, and partial mitogenomes from snake, skink, and lizard subfossils. Phylogenetic analyses confirm the extinct Columbretes snake as Vipera latastei, sharing a haplotype with the historical specimen and clustering with modern populations from northeastern Iberia, validating its provenance and suggesting a single mitochondrial lineage since isolation. The extinct skink, Chalcides bedriagai, also shows affinities with eastern Iberia. These results point to a vicariant origin for the herpetofauna, likely isolated on the island following sea level rise after the Last Glacial Maximum. Conversely, a 2,600-year-old mouse incisor yielded a Mus musculus mitogenome, indicating Iron Age human-mediated introduction. Additionally, genomic analysis of a 11th-century CE human burial revealed an individual with genetic affinities to the Central Mediterranean and Balkans, highlighting medieval maritime mobility. This study resolves the long-debated Columbretes snake identity, traces biogeographic origins and illustrates the interplay of natural isolation and anthropogenic influence on the island biodiversity.

ecology↗

bioRxiv2026

Co-occurrence of Yersinia pestis and other zoonoses during European prehistory

The infection of humans by the causal agent of Plague, Yersinia pestis, has been attested as far back as 5,500 BP. Although the specific patho-mechanism and ultimate origin of the disease caused by these prehistoric genomes remains unclear, the bacterium spread through Europe, likely during the Late Neolithic to Bronze Age (LNBA). In this study, we analysed 9 genomic samples originating from 8 different human individuals dating to around 4950 cal BP from the site of Grotta della Spinosa, Tuscany, Italy. Metagenomic screening of these samples reveals one individual (GSP013) to be co-infected by Yersinia pestis, Erysipelothrix rhusiopathiae, and Hepatitis B virus (HBV). At least three further individuals from the site were infected with HBV, indicating its wider presence within the community. The phylogenetic placement of Y. pestis in GSP013 shows that this strain is closely related to the earliest LNBA Caucasus genomes of the bacterium, basal to later European diversity. This represents the earliest evidence of Y. pestis in the Italian peninsula (and Southern Europe more widely) to date, predating previously discovered genomes by at least 200 years. Furthermore, we retrieved 60 newly reported ancient genomes of Erysipelothrix rhusiopathiae and Erysipelothrix tonsillarum from animals and humans, dating back from 8,300 BP to 100 BP. Of these new genomes, 15 of which stem from individuals known to be infected by Y. pestis. This contributes to our understanding of Y. pestis transmission in prehistoric Europe and possible reservoirs, and offers insights into disease dynamics in communities during the 3rd millennium BCE.

evolutionary biology↗

bioRxiv2023

Addressing heterogeneity in direct analysis of Extracellular Vesicles and analogues using Membrane-Sensing Peptides as Pan-Affinity Probes

Extracellular vesicles (EVs), crucial mediators of cell-to-cell communication, hold immense potential for diagnostic applications due to their ability to enrich protein biomarkers in body fluids. However, challenges in isolating EVs from complex biological specimens hinder their widespread use. In this frame, integrated isolation-and-analysis workflows are the go-to strategy, most of which see the prevalence of immunoaffinity methods. Yet, the high heterogeneity of EVs poses challenges, as proposed ubiquitous markers are less homogenously prevalent than believed, raising concerns about the reliability of downstream biomarker discovery programs. This issue extends to the burgeoning field of engineered EV-mimetics and bio-nanoparticles, where conventional immune-affinity methods may lack applicability. Addressing these challenges, we introduce the use Membrane Sensing Peptides (MSP) as "universal" affinity ligands for both EVs and EV-analogues. Employing a streamlined process integrating on-bead capture and vesicle phenotyping through Single Molecule Array (SiMoA) technology, we showcase the application of MSP ligands in the integrated analysis of circulating EVs in blood derivatives, eliminating the need for prior EV isolation. Demonstrating the possible clinical translation of MSP technology, we directly detect an EV-associated epitope signature in serum and plasma samples, demonstrating its potential for distinguishing patients with myocardial infarction versus stable angina. At last, notably, MSP exhibits a unique capability to enable the analysis of tetraspanin-lacking Red Blood Cell derived EVs (RBC-EVs). Overall, unlike traditional antibody-based methods, MSP probes work agnostically, overcoming limitations associated with surface protein abundance or scarcity. This highlights the potential of MSP in advancing EV analysis for clinical diagnostics and beyond. Of note, this represents also the first-ever peptide-based application in SiMoA technology.

biochemistry↗